UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~April 1~~May 26, 2009

NOVA BIOSOURCE FUELS, INC.

(Exact name of registrant as specified in its charter)

Nevada	000-32531	91-2028450
(State or other	(Commission File Number)	(I.R.S. Employer
Jurisdiction		Identification Number)
of incorporation)

109 North Post Oak Lane, Suite 422, Houston, Texas 77024

(Address of Principal Executive Offices)

713-869-6682

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 3 5.0102 ~~NOTICE~~DEPARTURE OF ~~DELISTING~~DIRECTORS OR ~~FAILURE~~CERTAIN TOOFFICERS; ~~SATISFY~~ELECTION AOF ~~CONTINUED~~DIRECTORS; APPOINTMENT ~~LISTING~~OF ~~RULE~~CERTAIN ~~OR STANDARD~~OFFICERS; ~~TRANSFER~~COMPENSATORY ARRANGEMENTS OF ~~LISTING~~CERTAIN OFFICERS

On ~~April 1~~May 26, 2009, ~~Nova Biosource~~Richard ~~Fuels, Inc.~~Talley ~~(the~~resigned ~~“Company”) received notice from NYSE Amex LLC, formerly known~~ as ~~the American Stock Exchange (the “Exchange”), indicating that~~Chief ~~the~~Operating ~~Exchange~~Officer ~~had suspended trading of the Company’s securities~~ and ~~had determined to seek to remove the Company’s securities~~ from ~~listing~~all ~~on the Exchange as a result of the Company’s filing of a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code and the Company’s failure to comply with certain~~ other ~~provisions~~positions of ~~the~~Nova ~~Exchange’s~~Biosource ~~Company Guide. The last day that the Company’s common stock traded on the Exchange was March 30~~Fuels, ~~2009~~Inc. ~~The~~ ~~Company does not intend to take any further action to appeal~~ (the ~~Exchange’s decision, and therefore it is expected that the~~ “Company’s”) ~~securities will be delisted after the completion of the Exchange’s application to the Securities~~ and ~~Exchange~~its ~~Commission~~subsidiaries.

~~ITEM 7.01 REGULATION FD DISCLOSURE~~Signature

~~Attached~~Pursuant to ~~hereto~~the asrequirements ~~Exhibit 99.1 is~~of the ~~news~~Securities ~~release~~Exchange ~~issued~~Act of 1934, the registrant has duly caused this report to be signed on its behalf by ~~Nova~~the ~~Biosource~~undersigned ~~Fuels, Inc~~hereunto duly authorized.

~~The~~NOVA ~~information~~BIOSOURCE ~~contained~~FUELS, ~~in Item 7~~INC.01 ofBy: ~~this~~/s/ ~~report~~Kenneth ~~and in Exhibit 99~~T.1 ~~shall~~Hern ~~not~~Kenneth beT. ~~deemed~~Hern ~~“filed” for~~Chairman ~~purposes~~and ofChief ~~Section 18~~Executive of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.Officer

~~ITEM~~Date: ~~9.01~~May 27, ~~FINANCIAL STATEMENTS AND EXHIBITS~~2009

99.1 News release dated April 3, 2009.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NOVA BIOSOURCE FUELS, INC.
	By:	/s/ Kenneth T. Hern
		Kenneth T. Hern
		Chairman, Chief Executive Officer and Chief Financial Officer
Date: April 3, 2009

EXHIBIT INDEX

99.1 News release dated April 3, 2009.

Filing Compare · NOVA BIOSOURCE FUELS, INC.